| __timestamp | Amphastar Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 382096000000 |
| Thursday, January 1, 2015 | 37065000 | 345927000000 |
| Friday, January 1, 2016 | 41199000 | 312303000000 |
| Sunday, January 1, 2017 | 43415000 | 325441000000 |
| Monday, January 1, 2018 | 57564000 | 368298000000 |
| Tuesday, January 1, 2019 | 68853000 | 492381000000 |
| Wednesday, January 1, 2020 | 67229000 | 455833000000 |
| Friday, January 1, 2021 | 60932000 | 526087000000 |
| Saturday, January 1, 2022 | 74771000 | 633325000000 |
| Sunday, January 1, 2023 | 73741000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Takeda Pharmaceutical Company Limited has consistently outpaced Amphastar Pharmaceuticals, Inc. in R&D investment. From 2014 to 2023, Takeda's R&D expenses surged by approximately 91%, reaching a staggering $730 billion in 2023. In contrast, Amphastar's R&D spending grew by about 160%, yet it remains a fraction of Takeda's, peaking at $74 million in 2022.
Takeda's strategic focus on R&D is evident, with a steady increase in spending, particularly after 2018. This aligns with their global expansion and acquisition strategies. Meanwhile, Amphastar's growth, though significant in percentage terms, highlights its niche focus and resource constraints. The data for 2024 is incomplete, suggesting ongoing developments in both companies' R&D strategies.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Celldex Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.